NCT03457922View on ClinicalTrials.gov

Evaluating a Personalized Trans-Diagnostic Group Therapy for Anxiety

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

August 21, 2019

Study Completion Date

October 6, 2019

Conditions
Anxiety Disorders
Trial Locations (1)

94304

Stanford University Department of Psychiatry & Behavioral Sciences, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER

NCT03457922 - Evaluating a Personalized Trans-Diagnostic Group Therapy for Anxiety | Biotech Hunter | Biotech Hunter